BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 8, 2008
View Archived Issues
ImaRx Shares Spike on Sale of Urokinase to Microbix
In a deal that sent shares of ImaRx Therapeutics Inc. soaring and spurred the creation of a spin-off company, Microbix Biosystems agreed to acquire urokinase inventory and related assets from ImaRx for $17 million in cash. (BioWorld Today)
Read More
Enzon to Spin Off its Biotech, Forming 2 Public Companies
Read More
Spectrum Sale of Profit Shares of Migraine Drug Nets $20M
Read More
Good Data on Riquent in Hand, La Jolla Seeks $30M Offering
Read More
ACT Biotech is Born with Pipeline, $12M
Read More
Earnings Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Clinic Roundup
Read More